AMAnja Pahlow Mose

Anja Pahlow Mose

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anja Pahlow Mose has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Colostomy May Improve Outcomes in Patients with Severe Anogenital and Gluteal Hidradenitis Suppurativa: Case Series

    by Valdis Thorhallsdottir, Karin Berggård, Meirav Holmdahl, Martin Lindsten, Louis Banka Johnson, Artur Schmidtchen, Anja Pahlow Mose

  • Open Access

    Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa

    by Anja Pahlow Mose, Usamah Adwa, Cecilia Svedman

    Is missing (Short communication)


  • The quest for ingested peanut protein in human serum

    by Anja Pahlow Mose, Ejvind Mortz, Per Stahl Skov, Charlotte Gotthard Mortz, Esben Eller, Ulrik Sprogøe, Torben Barington, Carsten Bindslev‐Jensen

    Background: There is mounting evidence that systemic uptake of food allergens is key to triggering anaphylaxis. However, direct proof for this theory is still lacking. The purpose of this study was to quantify the absorption and to determine the absorption kinetics of immunoreactive peanut protein in relation to the allergic response in human.Methods: Quantitative protein assays including mass spectrometry, dot blots and Western blotting were developed to determine the level of Ara h 2 absorption in human serum. The double monoclonal sandwich ELISA was applied to quantify absorbed Ara h 2 and 6, and the basophil histamine release assay and the human passive cutaneous anaphylaxis test were utilized to study the absorption kinetics of immunologically intact peanut proteins.Results: The protein assays worked but were not sensitive enough to trace the minute amounts of absorbed Ara h 2 in human serum. The level of Ara h 6 in serum was found to be up to 0.2 ng/mL, but Ara h 2 could not be detected with the ELISA. Both the in vivo and the in vitro methods were successful in demonstrating that: immunoreactive peanut protein was absorbed shortly after ingestion (≤5 minutes); the peanut protein concentration peaks between 1 and 4 hours; and peanut proteins can circulate for at least 48 hours in the bloodstream.Conclusion: Ingested peanut protein is absorbed systemically and retains its immunoreactive capacity in human serum. However, the precise quantities and the implication for the elicitation of anaphylaxis remains to be elucidated.


  • Antiviral treatment of a boy with EBV-associated hydroa vacciniforme

    by Anja Pahlow Mose, Niels Fisker, Ole Clemmensen, Anette Bygum

    Hydroa vacciniforme is one of the rarest forms of photosensitivity disorders of the skin. Effective treatment options are scarce and mainly constitute of strict sun protection. Lately, hydroa vacciniforme has been associated with Epstein-Barr virus infection. We present a patient with hydroa vacciniforme and concomitant previous/chronic Epstein-Barr virus infection. In this case, antiviral treatment was successful.


  • Allergic contact dermatitis from octylisothiazolinone

    by Anja P. Mose, Simon Frost, Ulf Öhlund, Klaus E. Andersen

    Background: Octylisothiazolinone is a biocide that has been reported as a moderate, but rare contact allergen.Objectives: To investigate the occurrence of octylisothiazolinone contact allergy and allergic contact dermatitis diagnosed and registered in the Allergen Bank at Odense University Hospital during the past 20 years. Octylisothiazolinone has been used for targeted testing only.Method: All octylisothiazolinone‐patch test results registered in the Allergen Bank between January 1992 and February 2012 were analyzed.Results: A total of 20 out of 648 patients patch tested with octylisothiazolinone had positive reactions. The majority of the patients (90%) with relevant sensitizations to octylisothiazolinone had been exposed in occupational settings and most patients were painters.Conclusions: Octylisothiazolinone is a relevant sensitizer.


  • Occupational contact dermatitis in painters – an analysis of patch test data from the Danish Contact Dermatitis Group

    by Anja P. Mose, Michael D. Lundov, Claus Zachariae, Torkil Menné, Niels K. Veien, Grete Laurberg, Knud Kaaber, Christian Avnstorp, Klaus E. Andersen, Evy Paulsen, et al.

    Background. Painters are among the occupational groups that most commonly experience occupational contact dermatitis, but few investigations exist concerning this occupation.Objectives. To characterize painters with contact dermatitis and identify the most common allergens associated with the occupation.Materials and methods. All patch test results of 219 painters and 1095 matched controls registered by the Danish Contact Dermatitis Group between 2001 and 2010 were analysed.Results. Hand eczema (p < 0.0001) and occupational contact dermatitis (p < 0.0001) were observed significantly more often in the painters than in the group of controls. Sensitizations to the following allergens from the European baseline series were associated with the occupation and were statistically significant: methylchloroisothiazolinone/methylisothiazolinone, epoxy resin, formaldehyde, and quaternium‐15. Three different isothiazolinones emerged as the most frequent sensitizers of the allergens tested in addition to the baseline series.Conclusions. The results indicate that painters have an increased risk of developing occupational hand eczema. Isothiazolinones and epoxy resin proved to be the two most frequent sensitizers in painters.


  • Flare‐up of dermatitis following patch testing is more common in polysensitized patients

    by Anja Pahlow Mose, Nathja Steenfeldt, Klaus Ejner Andersen